Acknowledgement
본 연구는 보건복지부의 재원으로 한국보건산업진흥원의 보건의료기술연구개발사업 지원에 의하여 이루어진 것임(HF20C0038).
References
- Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2018, Ministry of Health and Welfare, 2020. Available from: https://ncc.re.kr/cancerStatsView.ncc?bbsnum=558&searchKey=total&searchValue=&pageNum=1
- Chae JS, Jung GC, Kim SH, Yeon CH. Comparison of quality of life due to performance status in terminal cancer patients. Korean J Hosp Palliat Care 8(2):183-189, 2005
- Trajkovic-Vidakovic M, de Graeff A, Voest EE, Teunissen SC. Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol 84(1):130-148, 2012 https://doi.org/10.1016/j.critrevonc.2012.02.011
- Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102, 2009 https://doi.org/10.1186/1477-7525-7-102
- Cassileth BR, Deng G. Complementary and alternative therapies for cancer. The oncologist 9:80-89, 2004 https://doi.org/10.1634/theoncologist.9-1-80
- Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol 36(25):2647-2655, 2018 https://doi.org/10.1200/jco.2018.79.2721
- National Cancer Institute at the National Institutes of Health. Complementary and alternative medicine. Available from:URL: https://www.cancer.gov/about-cancer/treatment/cam
- Memorial Sloan Kettering Cancer Center. Integrative medicine. Available from:URL: https://www.mskcc.org/cancer-care/diagnosistreatment/symptom-management/integrativemedicine
- The University of Texas MD Anderson Cancer Center. Integrative medicine program. Available from:URL: http://www.mdanderson.org/CIMER
- Ministry of Ayush, Government of India. Ayush systems. Available from:URL:https://main.ayush.gov.in/
- Yoon SW, Lee JY, Kim EH, Yoon SS, Yoo HS, Joo JC, Park SJ, Jung HJ, Chung SY, Suh HW, Baek YH, Park YC. Korean medicine clinical practice guideline for cancer related symptoms. p. 210. Seoul, Koonja publishing, 2021
- Kim MH, Kang PS, Lee KS, Hwang TY, Maxwell AE. Utilization of complementary and alternative medicine of cancer patient in Korea. J Agric Med Community Health 32(3):155-167, 2007 https://doi.org/10.5393/JAMCH.2007.32.3.155
- Ahn YO. Cancer registration in Korea: the present and furtherance. J Prev Med Public Health 40(4):265-272, 2007 https://doi.org/10.3961/jpmph.2007.40.4.265
- National Cancer Data Center. The guideline for breast cancer registry version 1.0. Available from:URL: https://www.cancerdata.kr/supp/images/sub/brst_v1.0.pdf
- Kim MH, Kang PS, Lee KS, Hwang TY, Maxwell AE. Utilization of complementary and alternative medicine of cancer patient in Korea. J Agri Med & Community Health 32(3):155-167, 2007 https://doi.org/10.5393/JAMCH.2007.32.3.155
- Choi YJ, Lee JS, Cho SH. Use of Korean medicine among cancer patients. J Korean Oriental Med 33(3):46-53, 2012
- Park JM, Yoo SJ, Choi SY, Moon G, Lyu YS. Survey of motives for visiting oriental medical hospital and satisfaction with oriental medical care for cancer patients: report of 22 cases. J of Oriental Neuropsychiatry 26(1):23-38, 2015 https://doi.org/10.7231/JON.2015.26.1.023
- Ryu HS, Yoon SS, Lee JY, Yoon SW. Perspectives of cancer patients on Korean medicine treatments: a cross-sectional survey. J Int Koeran Med 38(3):319-326, 2017 https://doi.org/10.22246/jikm.2017.38.3.319
- Ryu HS, Lee JY, Oh HK, Yoon SW. A survey on Korean medicine doctors for cancer symptoms care in Korean medicine treatments. J of Kor Traditional Oncology 22(1):23-35, 2017 https://doi.org/10.15432/JKTO.2017.22.1.023
- Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat 52(2):335-350, 2020 https://doi.org/10.4143/crt.2020.206
- Luo Q, Asher GN. Complementary and alternative medicine use at a comprehensive cancer center. Integr Cancer Ther 16(1):104-109, 2017 https://doi.org/10.1177/1534735416643384
- Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK. Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care 14(5):326-334, 2008
- Rakovitch E, Pignol JP, Chartier C, Ezer M, Verma S, Dranitsaris G, Clemons M. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 90:139-148, 2005 https://doi.org/10.1007/s10549-004-3779-1
- Kremser T, Evans A, Moore A, Luxford K, Begbie S, Bensoussan A, Marigliani R, Zorbas H. Use of complementary therapies by Australian women with breast cancer. The Breast 17;387-394, 2008 https://doi.org/10.1016/j.breast.2007.12.006
- Jeong TY, Lee YW, Cho CK, Ypp HS. Analysis of clinical characteristics for 899 cancer patients treated at an oriental hospital. Korean J Orinet Int Med 31(1):102-112, 2010
- McQuade JL, Meng ZQ, Chen Z, Wei Q, Zhang Y, Bei WY, Palmer JL, Cohen L. Utilization of and attitudes towards traditional Chinese medicine therapies in a Chinese cancer hospital: a survey of patients and physicians. Evid Based Complementary Altern Med 2012:504507, 2012 https://doi.org/10.1155/2012/504507
- Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 23(12):2645-2654, 2005 https://doi.org/10.1200/JCO.2005.04.126
- Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AMA, Platin N, Kearney N, Patiraki E. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16(4):655-663, 2005 https://doi.org/10.1093/annonc/mdi110
- Choi W, Jung H, Kim K, Lee S, Yoon S, Park J, Kim S, Cheon S, Eo W, Lee S. Rhus verniciflua stokes against advanced cancer: a perspective from the Korean Integrative Cancer Center. J Biomed Biotechnol 2012:874276, 2012
- Bang JY, Kim KS, Kim EY, Yoo HS, Lee YW, Cho CK, Choi Y, Jeong HJ, Kang IC. Anti-angiogenic effects of the water extract of HangAmDan (WEHAD), a Korean traditional medicine. Sci China Life Sci 54(3):248-254, 2011 https://doi.org/10.1007/s11427-011-4144-3
- Kang HJ, Kim J, Cho SH, Park SJ, Yoo HS, Kang IC. Inhibitory effects of HangAmDan-B1 (HAD-B1) combined with afatinib on H1975 lung cancer cell-bearing mice. Integr Cancer Ther 18:1534735419830765, 2019 https://doi.org/10.1177/1534735419830765
- Lee K, Kim YS, Son CG, Cho JH, Yoo HS, Lee J, Ryu J, Lee N. Combination therapy of gefitinib and Korean herbal medicines could be a beneficial option for patients with non-small-cell lung cancer. J Pharmacopuncture 19(3):259-263, 2016 https://doi.org/10.3831/KPI.2016.19.028
- Kim KT, Eom HS, Lee IS, Kim JW, Chi GY. Study on standard symptoms and gender differences of Qi.Xue.Yin.Yang asthenia syndromes based on questionnaire analysis. Korean J Oriental Physiology & Pathology 20(6):1742-1748, 2006
- Lin JD, Lin JS, Chen LL, Chang CH, Huang YC, Su YC. BCQs: a body constitution questionnaire to assess stasis in traditional Chinese medicine. Eur J Integr Med 4(4):e379-e391, 2012 https://doi.org/10.1016/j.eujim.2012.05.001
- Lin SA, Chu PY, Chen LL, Su YC, Wang SM. The prevalence rate of deviations in body constitutions and related factors in follow-up stage breast cancer patients-A nationwide study. Complement Ther Med 32:49-55, 2017 https://doi.org/10.1016/j.ctim.2017.03.013
- Lin SC, Chen MF, Li TC, Hsieh YH, Liu SJ. The distribution of yin-deficient symptoms and their relationship on survival rate in cancer patients with Yin-Deficiency. Am J Chin Med 36(4):655-663, 2008 https://doi.org/10.1142/S0192415X08006120